Congenital heart disease

Trends in mortality risk of patients with congenital heart disease during the COVID-19 pandemic

Am Heart JPublished Retrospective cohort study

Main finding · All-cause mortalityResult — go to the resultAdjusted hazard ratio 1.28 95% CI 1.08–1.53

Authors' conclusion

In this large CHD cohort study, there was a higher risk of death among CHD patients with male and chromosomal abnormalities. A differential trend towards higher risk for those with two vs. unchanged risk for single ventricle CHD was presented. The excess mortality was attributed to the COVID-19 itself and not to conditions potentially related to deferral of care.

Study context

Population
US patients with congenital heart disease (CHD) from a US registry of CHD interventions, observation 2017–2022median age in 2017: 23.3 years
Participants
45,130 patients
Exposure
COVID-19 era vs pre-COVID-19 era
Outcome
All-cause mortality
Methodological detailsregistry-based (Pediatric Cardiac Care Consortium), stratified Cox model
  • Registry-based (Pediatric Cardiac Care Consortium)
  • Stratified Cox model

Main finding

As reported in the abstract

Adjusted hazard ratio

1.28

95% CI 1.08–1.53

COVID-19 eravs Pre-COVID-19 era
aHR 1.28 (95% CI 1.08–1.53)
Deaths during the pandemic
503

Observational data: associations, not effects.

Further findings

OutcomeaHR (95% CI)
All-cause mortality, by ventricular physiology (subgroup)COVID-19 eravs Pre-COVID-19 eraTwo-ventricle CHD1.44 (1.19–1.76)
All-cause mortality, by ventricular physiology (subgroup)COVID-19 eravs Pre-COVID-19 eraSingle ventricle CHD (unchanged risk)0.83 (0.57–1.21)

Deaths during the pandemic and deaths attributed to COVID-19

Deaths during the pandemic
503
Deaths attributed to COVID-19
44 (8.7%)
COVID-19 mortality rate
0.09%

All-cause mortality, by sex and chromosomal abnormalities (adjusted subgroup)

Higher risk of death during the pandemic for male CHD patients and those with chromosomal abnormalities

Cause of excess deaths

Excess deaths during the pandemic attributed to COVID-19 itself rather than CHD or CV conditions

Original publication

Trends in mortality risk of patients with congenital heart disease during the COVID-19 pandemic. Am Heart J. Published 14 November 2023. doi:10.1016/j.ahj.2023.11.010

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.